Skip to main content

Table 1 Demographic and clinical characteristics according to mortality

From: A prospective pilot study using metabolomics discloses specific fatty acid, catecholamine and tryptophan metabolic pathways as possible predictors for a negative outcome after severe trauma

  ALL
(n = 48)
SURVIVORS
(n = 43)
NON SURVIVORS
(n = 5)
p *
Age (years)a 47,5 ± 19 45,7 ± 19 63,0 ± 10 0,057
Sex (Male) (%) 85,4 83,7 100,0 0,438
Traffic (%) 62,5 62,8 60,0 0,706
Severe Brain Injury (Glasgow score < = 8) (%) 37,5 34,9 60,0 0,272
Glasgow (score) 13 ± 3 13 ± 3 14 ± 3 0,533
MV (%) 37,5 30,2 100,0 0,005
NA (%) 33,3 30,2 60,0 0,316
PaO2/FiO2 305 ± 111 310 ± 112 265 ± 99 0,429
LOS (days)b 13(8–24) 16(8–28) 9(4–14) 0,001
APACHE II 11,6 ± 6 10,7 ± 6 19,0 ± 5 0,010
ISS 19,0 ± 9 18,9 ± 9 20,2 ± 7 0,511
  1. Both APACHE II and ISS scores are directly proportional to severity of injury
  2. MV Mechanical ventilation, NA noradrenaline perfusion, PaO2/FiO2 Arterial Partial Pressure of Oxygen/Fraction of Inspired Oxygen, LOS Length of stay, APACHE II Acute Physiology and Chronic Health Evaluation II (ranges between 0 and 67), ISS Injury Severity Score (ranges between 0 and 75)
  3. *p value after group comparison by χ2 or Mann-Whitney test for continuous variables
  4. amean ± standard deviation
  5. bmedian (interquartile interval)